Last €77.17 EUR
Change Today +0.69 / 0.91%
Volume 14.5K
NOT On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Xetra
New York
OTC US
Mexico
SIX Swiss Ex
Frankfurt
As of 10:45 AM 12/29/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by NOVARTIS AG-REG (NOT) in the last 6 months

Announced 11/18/14
15.00M for Intellia Therapeutics Inc.
Private Placement

Intellia Therapeutics announced that it has received $15 million in its first round of funding co-led by new investors Atlas Venture L.P. and the research arm of Novartis AG. on November 18, 2014. Atlas Venture L.P. invested in the formation of the company.


NOT's price was unchanged after the transaction was announced on 11/18/14.
Investor / Buyer
Atlas Venture L.P.
Novartis AG
 
Announced 10/26/14
275.00M for Novartis AG, Influenza Vaccines Business
Merger/Acquisition

bioCSL Inc. entered into a definitive agreement to acquire influenza vaccines business from Novartis AG (SWX:NOVN) for approximately $280 million on October 26, 2014. The Novartis influenza vaccines unit will be combined with bioCSL. For the year ended December 31, 2013, influenza vaccines business posted sales of $527 million. The transaction requires regulatory approvals and is expected to close in the second half of 2015. Tim Duncan of Hintons & Associates acted as ...
Read More


NOT's price was unchanged after the transaction was announced on 10/26/14.
Investor / Buyer
bioCSL Inc.
Creditor / Lender
Novartis AG
 
Announced 10/14/14
24.00M for Raze Therapeutics, Inc.
Private Placement

Raze Therapeutics announced that it has received $24 million in its series A round of funding on October 14, 2014. The transaction included participation from new investors, Atlas Venture L.P., MPM Capital, Merck Serono S.A., Investment Arm, Partners Innovation Fund, Astellas Venture Management LLC, and Novartis AG. As part of the round, Ansbert Gadicke of MPM Capital, Nilesh Kumar of Merck Serono S.A., Investment Arm, Reza Halse of Partners Innovation Fund, Jason Rhodes ...
Read More


NOT's price was unchanged after the transaction was announced on 10/14/14.
Investor / Buyer
Astellas Venture Management LLC
Atlas Venture L.P.
Merck Serono S.A., Investment Arm
MPM Capital
Novartis AG
Partners Innovation Fund
 
Announced 07/28/14
16.00M for Seventh Sense Biosystems, Inc.
Private Placement

Seventh Sense Biosystems, Inc. announced that it will receive $16,467,084 in funding on July 28, 2014. The company will issue common shares, convertible debt and an option, warrant or other right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. As of August 8, 2014, the company has received $10,467,084 in its first tranche close from eight investors.


NOT's price was unchanged after the transaction was announced on 07/28/14.
Investor / Buyer
Flagship Ventures
Laboratory Corp. of America Holdings
Novartis AG
Polaris Partners
Siemens Financial Services, Inc.
 
Announced 07/17/14
LTS Lohmann Therapie-Systeme AG
Merger/Acquisition

dievini Hopp BioTech holding GmbH & Co. KG entered into an agreement to acquire additional 67% stake in LTS Lohmann Therapie-Systeme AG from BWK GmbH Unternehmensbeteiligungsgesellschaft and Novartis AG (SWX:NOVN) on July 16, 2014. The minority shareholders will receive an equivalent offer from dievini Hopp. LTS Lohmann Therapie-Systeme AG reported an annual turnover of more than €300 million. The transaction is subject to regulatory approvals, other customary conditions ...
Read More


NOT's price was unchanged after the transaction was announced on 07/17/14.
Investor / Buyer
dievini Hopp BioTech holding GmbH & Co. KG
Creditor / Lender
BWK GmbH Unternehmensbeteiligungsgesellschaft
Novartis AG
Financial Advisor
Morgan Stanley Bank AG
Legal Advisor
Morgan, Lewis & Bockius LLP
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOT:GR €77.17 EUR +0.69

NOT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $96.98 USD +3.19
Merck & Co Inc $57.79 USD +0.005
Pfizer Inc $31.47 USD -0.1801
Sanofi €75.80 EUR +0.81
Procter & Gamble Co/The $92.86 USD -0.60
View Industry Companies
 

Industry Analysis

NOT

Industry Average

Valuation NOT Industry Range
Price/Earnings 22.7x
Price/Sales 3.8x
Price/Book 3.2x
Price/Cash Flow 23.5x
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.